Extent of early ST segment elevation resolution: A strong predictor of outcome in patients with acute myocardial infarction and a sensitive measure to compare thrombolytic regimens. A substudy of the International Joint Efficacy Comparison of Thrombolytics (INJECT) trial

Journal of the American College of Cardiology

Volumn 26, Issue 7, 1995, Pages 1657-1664

  Schröder, Rolf ^a   Wegscheider, Karl ^a   Schröder, Klaus ^a   Dissmann, Rüdiger ^a   Meyer Sabellek, Wolfgang ^a  

^a German Coordinating Center of the INJECT Trial ^*  (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

RETEPLASE; STREPTOKINASE;

ACUTE HEART INFARCTION; ADULT; AGED; ARTICLE; BLOOD CLOT LYSIS; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; ELECTROCARDIOGRAM; FEMALE; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; MAJOR CLINICAL STUDY; MALE; MORTALITY; MULTICENTER STUDY; PRIORITY JOURNAL; PROGNOSIS; RANDOMIZED CONTROLLED TRIAL; ST SEGMENT ELEVATION; TREATMENT OUTCOME;

AGED; DOUBLE-BLIND METHOD; ELECTROCARDIOGRAPHY; FEMALE; FIBRINOLYTIC AGENTS; HUMANS; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; PLASMINOGEN ACTIVATORS; PROGNOSIS; PROSPECTIVE STUDIES; RECOMBINANT PROTEINS; STREPTOKINASE; THROMBOLYTIC THERAPY; TISSUE PLASMINOGEN ACTIVATOR;

EID: 0028880573     PISSN: 07351097     EISSN: None     Source Type: Journal    
DOI: 10.1016/0735-1097(95)00372-X     Document Type: Article

References (25)

1. Reduction in ST segment elevation after thrombolysis predicts either coronary reperfusion or preservation of left ventricular function
2. Rapid resolution of ST elevation and prediction of clinical outcome in patients undergoing thrombolysis with alteplase (recombinant tissue-type plasminogen activator): results of the Israeli Study of Early Intervention in Myocardial Infarction
3. A simple electrocardiographic predictor of the outcome of patients with acute myocardial infarction treated with a thrombolytic agent
4. Early assessment of outcome by ST-segment analysis after thrombolytic therapy in acute myocardial infarction
5. Erkennung der frühen Reperfusion und Vorhersage der linksventrikulären Schädigung aus dem Verlauf der ST-Strecken-Hebung beim akuten Myokardinfarkt mit Thrombolyse
6. A prospective trial of intravenous streptokinase in acute myocardial infarction (ISAM)
7. Extent of early ST segment elevation resolution a simple but strong predictor of outcome in patients with acute myocardial infarction
8. A randomized double blind comparison of reteplase 10 + 10 MU double bolus administration with streptokinase in patients with acute myocardial infarction (INJECT)
9. Significance of initial ST segment elevation and depression for the management of thrombolytic therapy in acute myocardial infarction
10. Use of initial ST-segment deviation for prediction of final electrocardiographic size of acute myocardial infarcts
11. Significance of a coronary artery with thrombolysis in myocardial infarction grade 2 flow “potency” (outcome in the Thrombolysis and Angioplasty in Myocardial Infarction Trials)
12. Changes in standard electrocardiographic ST-segment elevation predictive of successful reperfusion in acute myocardial infarction
13. ST segment analysis for assessment of coronary artery potency: comparison of surface ECG and Holter recordings
14. Comparison of continuous ST-segment recovery analysis with methods using static electrocardiograms for noninvasive potency assessment during acute myocardial infarction
15. Continuous 12-lead ST segment recovery analysis in the TAMI 7 Study
16. Is ST segment re-elevation associated with reperfusion an indicator of marked myocardial damage after thrombolysis?
17. Sudden increase of the ST segment elevation at the time of reperfusion predicts extensive infarcts in patients with intravenous thrombolysis
18. Dose finding with a novel recombinant plasminogen activator (BM 06.022) in patients with acute myocardial infarction: results of the German Recombinant Plasminogen Activator Study (GRECO)
19. Open, non-controlled dose finding study with a novel recombinant plasminogen activator (BM 06.022) given as a double bolus in patients with acute myocardial infarction
20. More rapid, complete, and stable coronary thrombolysis with bolus administration of reteplase compared with alteplase infusion in acute myocardial infarction
21. Reteplase vs alteplase potency investigation during myocardial infarction trial (RAPID 2)
22. Improved thrombolysis with a modified dose regimen of recombinant tissue-type plasminogen activator
23. An international randomized trial comparing four thrombolytic strategies for acute myocardial infarction
24. An approach to evaluating thrombolytic therapy in acute myocardial infarction
25. Randomized comparison of rescue angioplasty with conservative management of patients with early failure of thrombolysis for acute anterior myocardial infarction